These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7595651)

  • 1. Regional alterations in M1 muscarinic receptor-G protein coupling in Alzheimer's disease.
    Ladner CJ; Celesia GG; Magnuson DJ; Lee JM
    J Neuropathol Exp Neurol; 1995 Nov; 54(6):783-9. PubMed ID: 7595651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in regional and subcellular localization of G(q/11) and RGS4 protein levels in Alzheimer's disease: correlation with muscarinic M1 receptor binding parameters.
    Muma NA; Mariyappa R; Williams K; Lee JM
    Synapse; 2003 Jan; 47(1):58-65. PubMed ID: 12422374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced high-affinity agonist binding at the M(1) muscarinic receptor in Alzheimer's disease brain: differential sensitivity to agonists and divalent cations.
    Ladner CJ; Lee JM
    Exp Neurol; 1999 Aug; 158(2):451-8. PubMed ID: 10415152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies.
    Flynn DD; Weinstein DA; Mash DC
    Ann Neurol; 1991 Mar; 29(3):256-62. PubMed ID: 2042942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coupling of muscarinic receptors to GTP proteins in postmortem human brain--alterations in Alzheimer's disease.
    Warpman U; Alafuzoff I; Nordberg A
    Neurosci Lett; 1993 Feb; 150(1):39-43. PubMed ID: 8469400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic cholinergic receptor subtypes in normal human brain and Alzheimer's presenile dementia.
    Vanderheyden P; Ebinger G; Dierckx R; Vauquelin G
    J Neurol Sci; 1987 Dec; 82(1-3):257-69. PubMed ID: 3440867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered G-protein coupling of a frontal cortical low affinity [3H]8-hydroxy-N,N-dipropyl-2-aminotetralin serotonergic binding site in Alzheimer's disease.
    Weinstein D; Magnuson D; Lee J
    Behav Brain Res; 1996; 73(1-2):325-9. PubMed ID: 8788528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of muscarinic receptor-G-protein interaction in Alzheimer disease.
    Ferrari-DiLeo G; Mash DC; Flynn DD
    Mol Chem Neuropathol; 1995 Jan; 24(1):69-91. PubMed ID: 7755848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential alterations in muscarinic receptor subtypes in Alzheimer's disease: implications for cholinergic-based therapies.
    Flynn DD; Ferrari-DiLeo G; Levey AI; Mash DC
    Life Sci; 1995; 56(11-12):869-76. PubMed ID: 10188787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential coupling between muscarinic receptors and G-proteins in regions of the rat brain.
    Ghodsi-Hovsepian S; Messer WS; Hoss W
    Biochem Pharmacol; 1990 Apr; 39(8):1385-91. PubMed ID: 2108689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different agonist-receptor active conformations for rat brain M1 and M2 muscarinic receptors that are separately coupled to two biochemical effector systems.
    McKinney M; Anderson D; Vella-Rountree L
    Mol Pharmacol; 1989 Jan; 35(1):39-47. PubMed ID: 2536467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease in GTP-sensitive high affinity agonist binding of muscarinic acetylcholine receptors in autopsied brains of dementia with Lewy bodies and Alzheimer's disease.
    Shiozaki K; Iseki E
    J Neurol Sci; 2004 Aug; 223(2):145-8. PubMed ID: 15337615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diminished muscarinic receptor-stimulated [3H]-PIP2 hydrolysis in Alzheimer's disease.
    Ferrari-DiLeo G; Flynn DD
    Life Sci; 1993; 53(25):PL439-44. PubMed ID: 8255145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylcholine muscarinic M2 receptor stimulated [35S]GTP gamma S binding shows regional selective changes in Alzheimer's disease postmortem brain.
    Cowburn RF; Wiehager B; Ravid R; Winblad B
    Neurodegeneration; 1996 Mar; 5(1):19-26. PubMed ID: 8731378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coupling of m1 muscarinic receptors to G protein in Alzheimer disease.
    Pearce BD; Potter LT
    Alzheimer Dis Assoc Disord; 1991; 5(3):163-72. PubMed ID: 1772636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guanine nucleotide modulation of muscarinic cholinergic receptor binding in postmortem human brain--a preliminary study in Alzheimer's disease.
    Smith CJ; Perry EK; Perry RH; Fairbairn AF; Birdsall NJ
    Neurosci Lett; 1987 Nov; 82(2):227-32. PubMed ID: 3696495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of alkylating agents on the multiple muscarinic receptor subtypes linked to activation of phospholipase C by carbachol in rat brain cortical membranes.
    Sallés J; Wallace MA; Fain JN
    J Pharmacol Exp Ther; 1993 Feb; 264(2):521-9. PubMed ID: 8437104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse agonist activity of pirenzepine at M2 muscarinic acetylcholine receptors.
    Daeffler L; Schmidlin F; Gies JP; Landry Y
    Br J Pharmacol; 1999 Mar; 126(5):1246-52. PubMed ID: 10205015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
    Flynn DD; Mash DC
    Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.